Professor Peter Sandercock
Emeritus Professor of Medical Neurology

- Centre for Clinical Brain Sciences
Contact details
- Tel: 0131 465 9602
- Email: peter.sandercock@ed.ac.uk
Background
Studied Medicine at the University of Oxford, and undertook my postgraduate clinical training in Stoke-on-Trent, Manchester, Oxford and Liverpool, followed by a visiting academic fellowship at McMaster University Canada. My initial research was on the epidemiology of stroke in Oxfordshire, and in clinical trials of stroke prevention.
I set up and ran the first International Stroke Trial (IST-1), the first ‘mega-trial’ in acute ischaemic stroke from 1991-1997.19,453 patients were recruited within 48 hours of stroke onset from 467 hospitals in 37 countries. I was the Co-Chief Investigator of IST-3, the largest-ever trial of ‘clot-busting’ thrombolytic therapy for acute ischaemic stroke with 3035 patients. I have a major interest in clinical trials, systematic reviews and Evidence-Based Medicine.
My main academic activities in retirement relate to clinical trial research governance though membership or Chairmanship of Trial Steering Committes and Trial Data Monitoring Committees.
Qualifications
BM, BCh, MA, DM
Research summary
In retirement, I support fellow scientist in doing their own clinical trials, but have no active research projects of my own
-
Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19
(9 pages)
In:
Trials, vol. 23
DOI: https://doi.org/10.1186/s13063-022-06824-6
Research output: Contribution to Journal › Article (Published) -
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials
In:
BMC Medical Research Methodology, vol. 21
DOI: https://doi.org/10.1186/s12874-021-01388-6
Research output: Contribution to Journal › Article (Published) -
Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial
In:
JAMA Neurology
DOI: https://doi.org/10.1001/jamaneurol.2021.2956
Research output: Contribution to Journal › Article (E-pub ahead of print) -
Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) – study protocol for a randomised controlled trial
(7 pages)
In:
European Stroke Journal, vol. 6, pp. 222-228
DOI: https://doi.org/10.1177/2396987320972566
Research output: Contribution to Journal › Article (E-pub ahead of print) -
Real-world Independent Testing of e-ASPECTS Software (RITeS): statistical analysis plan
In:
AMRC Open Research, vol. 2, pp. 20
DOI: https://doi.org/10.12688/amrcopenres.12904.1
Research output: Contribution to Journal › Article (Published)